TMPRSS2 and prostate carcinoma: The TMPRSS2:ERG fusion protein has been discussed as a prognostic marker for prostate cancer in urine and tissue27 and was described to be overexpressed in prostate cells and shed in prostasomes28, however this has not previously been associated with UBC.